Robert F. Kennedy Jr. will appear as President Donald Trump's nominee for Secretary of the Department of Health and Human ...

Speaking about obesity and diabetes, RFK Jr. said he would rather provide people with organic food three times a day than ...

Kennedy is nominated to lead the Department of Health and Human Services, a position that would give him enormous control ...

The conversation surrounding healthcare reform has intensified in recent years, revealing deep divides in how we view ...

As the next round of Medicare drug pricing negotiations get underway, experts predict President Trump may seek to weaken the program.

A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

Ozempic and Wegovy have been added to Medicare's list of drugs, whose prices will be negotiated between drug makers and the government.

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with ...

Concern is growing among Democrats after President Donald Trump reversed some of the former president’s executive orders, ...

Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...

Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...